AstraZeneca Halts Investment Amid UK Pharma Challenges
AstraZeneca has paused a significant £200 million investment in its Cambridge research site, impacting planned job creation. This follows the abandonment of a £450 million investment in northern England and highlights wider concerns about the UK's business climate for pharmaceutical companies.
AstraZeneca, Britain's largest company by market value, has suspended its £200 million investment in a Cambridge research facility, according to a company spokesperson. This decision, impacting 1,000 anticipated jobs, represents the latest setback fo... [605 chars]
Published by: Devdiscourse
Read full article here: https://www.devdiscourse.com/article/business/3626267-astrazeneca-halts-investment-amid-uk-pharma-challenges
